AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5474.00p Today's change: +0.13%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5474.00p 5 day change: +0.74%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5474.00p 6 month change: +9.77%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

Pharmaceutical companies AstraZeneca and Eli Lilly have decided to end the phase III trials of Lanabecestat, a [...]

12 June 2018
Shares
1
Views
292

Anglo-Swedish pharma company AstraZeneca has revealed that its severe asthma drug Fasenra failed to meet its second [...]

30 May 2018
Views
200

Competition to AstraZeneca's cholesterol drug Crestor plagued the company's first quarter, but the company said [...]

18 May 2018
Views
232

The boards at several big-name companies will face a barrage of investor questions this week, as shareholders [...]

14 May 2018
Shares
4
Views
1,318

Shares at pharmaceutical company Redx have rocketed this morning, climbing almost 70 per cent following yesterday's [...]

25 April 2018
Views
791

Dividends at UK-listed companies have crept up just slightly in the first quarter of 2018 to £16.7bn, as lack [...]

23 April 2018
Shares
4
Views
321

Major UK firms have told ministers of their fears that Brexit could leave them facing a shortfall of workers. [...]

1 April 2018
Shares
29
Views
6,571

Drugs giant AstraZeneca has pushed back the announcement of results from a key study of lung cancer treatments [...]

12 March 2018
Shares
3
Views
549

AstraZeneca suffered a fall in revenue last year as its product sales declined. [...]

2 February 2018
Views
408

One of the world's top pharmaceuticals companies will report its results this week following a spate of recent [...]

28 January 2018
Shares
5
Views
922

Some of the world's biggest pharmaceutical firms have warned the government a no-deal Brexit "poses a serious [...]

4 December 2017
Shares
6
Views
256

AstraZeneca has lifted its full-year core earnings guidance this morning, as the pharmaceuticals giant began to [...]

9 November 2017
Views
519

British pharmaceuticals giant AstraZeneca has snapped up a stake in Neil Woodford and Novartis-backed Mereo [...]

30 October 2017
Views
445

The chairman of pharmaceuticals giant AstraZeneca is hoping Britain and Brussels agree a transition period of [...]

2 October 2017
Shares
4
Views
585

The lack of progress in Brexit negotiations prevented the boss of Astrazeneca from signing a letter of support [...]

9 September 2017
Shares
4
Views
1,132

Content tagged with "AstraZeneca"